These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15726119

  • 1. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.
    Hilmy M, Bartlett JM, Underwood MA, McMillan DC.
    Br J Cancer; 2005 Feb 28; 92(4):625-7. PubMed ID: 15726119
    [Abstract] [Full Text] [Related]

  • 2. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T, Tomic R, Ljungberg B.
    Scand J Urol Nephrol; 2009 Feb 28; 43(4):293-9. PubMed ID: 19363744
    [Abstract] [Full Text] [Related]

  • 3. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z, Eryigit M.
    Int Urol Nephrol; 1993 Feb 28; 25(3):255-7. PubMed ID: 8225826
    [Abstract] [Full Text] [Related]

  • 4. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug 28; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 5. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
    Margel D, Tal R, Baniel J.
    J Urol; 2007 Dec 28; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 28; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H.
    J Urol; 2006 Jul 28; 176(1):48-52. PubMed ID: 16753365
    [Abstract] [Full Text] [Related]

  • 8. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 9. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
    Lamb GW, McArdle PA, Ramsey S, McNichol AM, Edwards J, Aitchison M, McMillan DC.
    BJU Int; 2008 Sep 20; 102(6):756-61. PubMed ID: 18384626
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
    Ramsey S, Lamb GW, Aitchison M, McMillan DC.
    BJU Int; 2008 Apr 20; 101(8):959-63. PubMed ID: 18190639
    [Abstract] [Full Text] [Related]

  • 11. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun 20; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

  • 12. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE.
    J Urol; 2005 Jun 20; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
    Mbeutcha A, Shariat SF, Rieken M, Rink M, Xylinas E, Seitz C, Lucca I, Mathieu R, Rouprêt M, Briganti A, Karakiewicz PI, Klatte T.
    Urol Oncol; 2016 Nov 20; 34(11):483.e17-483.e24. PubMed ID: 27646875
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K.
    BJU Int; 2008 Apr 20; 101(8):978-81. PubMed ID: 18190628
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 20; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 20; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 17. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW.
    J Urol; 2007 Dec 20; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [Abstract] [Full Text] [Related]

  • 18. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb 20; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 19. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
    Crozier JE, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC.
    Am J Surg; 2009 Apr 20; 197(4):544-9. PubMed ID: 18614139
    [Abstract] [Full Text] [Related]

  • 20. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
    Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S.
    BJU Int; 2007 Jul 20; 100(1):33-6. PubMed ID: 17552951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.